Pain Management

NHS England (2013 data) suggests that approximately 14 million people live with persistent or chronic pain in the UK. This affects their health, quality of life and ability to work. Napp have been committed to furthering the understanding and treatment of pain for over 30 years.

BuTrans® patches (7-day buprenorphine patches)

Patient Information Leaflet

DHC® Continus® tablets (prolonged release dihydrocodeine tartrate)

Patient Information Leaflet

MST® Continus® tablets (prolonged release morphine sulphate)

Patient Information Leaflet

MST® Continus® suspension (prolonged release morphine sulphate)

Patient Information Leaflet

MXL® capsules (prolonged release morphine sulphate)

Patient Information Leaflet

OxyContin® tablets (prolonged release oxycodone hydrochloride)

5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg and 120 mg prolonged release tablets

Patient Information Leaflet

OxyNorm® capsules (immediate release oxycodone hydrochloride)

Patient Information Leaflet

OxyNorm® injection (oxycodone hydrochloride)

10mg/ml

Patient Information Leaflet

50mg/ml

Patient Information Leaflet

OxyNorm® oral liquid (immediate release oxycodone hydrochloride)

Patient Information Leaflet

OxyNorm® oral concentrate (immediate release oxycodone hydrochloride)

Patient Information Leaflet

Palladone® SR capsules (prolonged release hydromorphone hydrochloride)

Patient Information Leaflet

Palladone® capsules (immediate release hydromorphone hydrochloride)

Patient Information Leaflet

Sevredol® tablets (immediate release morphine sulphate)

Patient Information Leaflet

Targinact® tablets (prolonged release oxycodone hydrochloride/naloxone hydrochloride dihydrate)

Patient Information Leaflet

Transtec® patches (twice-weekly buprenorphine patches)

Patient Information Leaflet